Member Info for graking

https://uk.motor1.com/news/443134/new-graphene-superbattery-charge-15-seconds/?utm_source=msn.com&utm_medium=referral&utm_campaign=msn-feed

The CPX ultra thin capacitor is some years old now. May still be a world leader at its size and capability but am not sure about that. From what I know about Elon Musk, he ventures into the newest of technologies and innovations and I am unaware he collects subsidiaries as small as CPX. If anything, I suspect he might simply cough up and then sue his external Maxwell acquisition solicitors for not having undertaken due diligence.

Spo-key -I too have considered this issue. Why would CPX want to take back the manufacturing process with all the associated headaches. Can think of two reasons. First the Ozzy Government grants for setting up a manufacturing exporter, Second the profit margin has to be greater and third, they are in a position to undertake direst marketing and to multiply production very quickly as the need arises. On a fourth though less obvious point, were they to develop a new capacitor design, it has to be tested to production level to see how practicable and inexpensive mass production might be. Something you would find difficulty with via a re-seller such as Murata. In a more general answer, you may as well ask why Dyson makes its own devices rather than sub contracting to a third party. On this point I could give manufacturing examples forever and a day

sharedealer2019 All you have done is send me a report that Covid affects the elderly more seriously than the young. We all know that. You consistently fail to show me where in Synairgens results it is shown to be as effective in the older cohort I repeat - Synairgens results as published fail to show any age related correlation and one can easily conclude that the 79% success rate was amongst the younger cohort. Who might have improved without the need for ventilation in any case. A major and perhaps intentional omission by Synairgen. Sorry to say that my so called "deramping" has driven the share price down a couple of points but you would have known that would happen.

Lat drilling report one month ago. A monthly report would make sense.

DavetheDumplin-your name speaks volumes. be serious in your replies or I might have to attempt to insult you and call you a ramper.

Sharedealer2019 - Please respond sensibly to my question "what evidence i s their that we so called derampers who merely question matters are adversely affecting share demand or the share price. Or do you have it in some mysterious Powerpoint. Come on , step up and try to answer one question at the very least

Sharedealer2019. As you are so well informed, what does their Powerpoint say about the successes or failures in the different age groups. Tell me how I can access this PowerPoint and if it shows I am wrong, I will publicly apologise. Come on step up.

Jakman59 You are over simplifying because it suits your position. Where is the breakdown showing the extent this works as well in the older as well as the younger cohort. After all, its by far the elderly who suffer most and more likely to die and who would be prioritised in a phased introduction. A significant omission in the reported findings. Synairgen still not answering my query.

Sheredealer2019 - For once please read the message and apply your intelligence instead of bleating about someone being a deramper. Do you really believe that my questioning approach will affect the share value. And if you do somehow believe that, where is your evidence - come on lets see it. Oops forgot - you don't look at the facts but should you do so on this one instance, just what is your view on the absence of any mention about immunosenescence in Syns RNS's ?

and probably drop slightly till they publish their latest trading results or get a new deal.

The RNS is welcome but not one of earthshattering dimensions like a new and improved product or even a takeover. From now on its a matter of watching the profitability and guessing when the shareholders might receive dividends.

Look up tis word then ask Synairgen to what extent this has featured in their trials. Vital for otherwise, the trials might be significantly biased. Have written to Synairgen and await their response. Others need to ask them the same question.

Price still struggling yet Barrick Gold rises by almost 4% at this moment. I wonder if all gold stocks are in the ascendancy. Perhaps gold price will rise this week and the gold stock market is buzzing

So lucky this mine is not in the UK. Would be closed by now by our "from another Planet Government"

Brent and crude prices will follow the Bears as the inevitable economic depression kicks in. Gold will reach significant highs. My thinking is a January significant downturn once the Q3 economic figures are released for the UK and US

CEO said on 11 August expected to issue an operational update "every week or two". Perhaps he has decided to issue one on a monthly basis as that will have a much bigger impact. Today ?

Robertsmith. So what was the number this time ?

But not a s big a drop post closure as I thought. Hopefully that bodes well for tomorrow.

Very sensible interview explaining the way forward as per the RNS. If the data set is "as strong" as he states (whatever strong means) then the declared need for future funding should lead to an RNS this week naming a big investor. Delays here might suggest the results are not as strong or encouraging as he hoped. The first to fund this through to manufacturing is the outright winner. One of my main worries is that the data shows that it is safe. But then so is Aspirin largely. And no stats as to success or failure.